Leukocytes, Mononuclear < Levodopa < Lewy Bodies

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 356.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (1999)	F. Durif [France] ; M. Vidailhet ; B. Debilly ; Yves Agid [France]	Worsening of levodopa-induced dyskinesias by motor and mental tasks.
000012 (1999)	L. Defebvre [France] ; P. Derambure ; J L Bourriez ; A. Destée ; J D Guieu	[Event-related desynchronization and Parkinson disease. Importance in the analysis of the phase of preparation for movement].
000013 (1998)		Ropinirole: new preparation. Wait for more convincing data.
000016 (1999)	S. Hunot [France] ; N. Dugas ; B. Faucheux ; A. Hartmann ; M. Tardieu ; P. Debré ; Yves Agid [France] ; B. Dugas ; E C Hirsch	FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
000020 (1999)	B P Bejjani [France] ; P. Damier ; I. Arnulf ; L. Thivard ; A M Bonnet ; D. Dormont ; P. Cornu ; B. Pidoux ; Y. Samson ; Yves Agid [France]	Transient acute depression induced by high-frequency deep-brain stimulation.
000027 (1999)	P. Krack [France] ; P. Pollak ; P. Limousin ; A. Benazzouz ; G. Deuschl ; A L Benabid	From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
000036 (1999)	O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc	Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000037 (1999)	P. Damier [France]	New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
000047 (????)	H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
000056 (1999)	Yves Agid [France]	Parkinson's disease or Parkinson's diseases?
000058 (1999)	E. Broussolle [France] ; C. Dentresangle ; P. Landais ; L. Garcia-Larrea ; P. Pollak ; B. Croisile ; O. Hibert ; F. Bonnefoi ; G. Galy ; J C Froment ; D. Comar	The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
000061 (1999)	M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]	The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000062 (1999)	O. Rascol [France]	L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000064 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.
000073 (1999)	M. Gentil [France] ; C L Tournier ; P. Pollak ; A L Benabid	Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000080 (1999)	Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa	Levodopa in the treatment of Parkinson's disease: a consensus meeting.
000081 (1999)	C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. Brousolle	Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000083 (1999)	S. Mesure [France] ; J P Azulay ; J. Pouget ; B. Amblard	Strategies of segmental stabilization during gait in Parkinson's disease.
000085 (1999)	L. Vercueil [France] ; J P Linard ; B. Wuyam ; P. Pollak ; G. Benchetrit	Breathing pattern in patients with Parkinson's disease.
000087 (2000)	S. Rivaud-Pechoux ; A. Vermersch ; B. Gaymard ; C. Ploner ; B. Bejjani ; P. Damier ; S. Demeret ; Yves Agid [France] ; C. Pierrot-Deseillig.	Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation
000091 (2000)	T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E Gross	Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Levodopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Levodopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Levodopa
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024